Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT - About
Tema Neuroscience and Mental Health ETF (MNTL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: MNTL (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Outstanding Performance
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
Analysis of Past Performance
Type ETF | Historic Profit 0.2% | Avg. Invested days 70 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  5.0 | ETF Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Volume (30-day avg) 733 | Beta - | 52 Weeks Range 22.35 - 27.39 | Updated Date 04/1/2025 |
52 Weeks Range 22.35 - 27.39 | Updated Date 04/1/2025 |
Upturn AI SWOT
Tema Neuroscience and Mental Health ETF
ETF Overview
Overview
The Tema Neuroscience and Mental Health ETF (MENT) focuses on investing in companies that are developing treatments, technologies, and services related to neuroscience and mental health. It aims to capture growth opportunities in this emerging healthcare sector.
Reputation and Reliability
Tema ETFs are relatively new to the market, but their focus on thematic investing has garnered attention. It's crucial to monitor their performance and track record over time.
Management Expertise
The ETF's management team possesses experience in thematic investing and healthcare sectors, providing valuable insight into identifying promising companies in the neuroscience and mental health space.
Investment Objective
Goal
To provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Tema Neuroscience and Mental Health Index.
Investment Approach and Strategy
Strategy: The ETF tracks an index comprised of companies involved in the neuroscience and mental health industry, focusing on those developing or utilizing treatments and technologies in this field.
Composition The ETF primarily holds stocks of companies in the healthcare, biotechnology, and technology sectors that are involved in the treatment, research, and support of mental health and neurological disorders.
Market Position
Market Share: Data regarding MENT's specific market share is limited due to the niche and nascent nature of the neuroscience and mental health ETF market.
Total Net Assets (AUM): Precise AUM data should be sourced from official financial data providers.
Competitors
Key Competitors
Competitive Landscape
The competitive landscape for neuroscience and mental health ETFs is currently limited due to the specialization of the sector. As the sector grows, increased competition from broader healthcare or biotech ETFs is possible. MENT's advantages lie in its targeted approach and potential for high growth, while a disadvantage is the inherent risk associated with investing in a niche sector.
Financial Performance
Historical Performance: Historical performance data should be sourced from official financial data providers and analyzed over different time periods (e.g., 1 year, 3 years, 5 years).
Benchmark Comparison: To assess the ETF's effectiveness, its performance should be compared to relevant healthcare or biotechnology indices.
Expense Ratio: Precise expense ratio data should be sourced from official financial data providers.
Liquidity
Average Trading Volume
Assess the average trading volume through official financial data providers to understand the liquidity of the ETF.
Bid-Ask Spread
Obtain the bid-ask spread from financial data providers to determine the cost of trading the ETF.
Market Dynamics
Market Environment Factors
The ETF is affected by factors such as advancements in neuroscience, regulatory changes in healthcare, and the overall growth of the biotechnology and pharmaceutical industries.
Growth Trajectory
Monitor changes in strategy, holdings, and market focus to understand the growth trends of the ETF, as well as overall market changes.
Moat and Competitive Advantages
Competitive Edge
MENT's competitive edge lies in its focused approach on the neuroscience and mental health sector, capitalizing on the increasing awareness and investment in mental health solutions. Its investment strategy is targeted towards companies developing innovative therapies and technologies. The ETF benefits from the growing demand for mental health treatments and the limited number of specialized investment vehicles in this area.
Risk Analysis
Volatility
Assess the ETF's historical volatility by analyzing its price fluctuations and beta.
Market Risk
The ETF is exposed to market risks related to the healthcare and biotechnology sectors, including regulatory hurdles, clinical trial failures, and competition from other companies.
Investor Profile
Ideal Investor Profile
The ideal investor for MENT is someone with a high risk tolerance and an interest in the healthcare and biotechnology sectors. It's appropriate for those seeking exposure to the growing field of neuroscience and mental health.
Market Risk
MENT is suitable for long-term investors who believe in the growth potential of the neuroscience and mental health industry. It's not recommended for risk-averse investors due to the volatility associated with the sector.
Summary
The Tema Neuroscience and Mental Health ETF (MENT) offers focused exposure to companies at the forefront of neuroscience and mental health. It is suitable for long-term investors with high risk tolerance and interest in healthcare. The ETF is subject to market risks related to regulations, clinical trials, and competition. Its performance should be continuously compared against its benchmark and other healthcare indices, and the fund is suitable for investors who see potential growth in the neuroscience and mental health sector.
Similar Companies
IBB
iShares Biotechnology ETF
IBB
iShares Biotechnology ETF
XBI
SPDR® S&P Biotech ETF
XBI
SPDR® S&P Biotech ETF
XLV
Health Care Select Sector SPDR® Fund
XLV
Health Care Select Sector SPDR® Fund
Sources and Disclaimers
Data Sources:
- Official ETF provider website
- Financial data providers (e.g., Bloomberg, Reuters)
- SEC filings
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Investment decisions should be based on individual circumstances and consultation with a financial advisor. Past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Tema Neuroscience and Mental Health ETF
Exchange NASDAQ | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies. A company is generally considered to be a neuroscience or mental health company that derives at least 50% of revenues from neuroscience or neurology-related diseases, or mental health. The fund is non-diversified.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.